Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κb transcription factors

Circulation Research

Volumn 84, Issue 6, 1999, Pages 695-703

  Han, Youqi ^a   Runge, Marschall S ^b   Brasier, Allan R ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Angiotensin II; Cytokine; Nuclear factor B; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN INHIBITOR; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033515524     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.6.695     Document Type: Article

References (40)

1. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
2. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. Hypertension. 1997;29: 366-373.
3. Hershey JC, Hautman M, Thompson MM, Rothblum LI, Haystead TAJ, Owens GK. Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor. J Biol Chem. 1995;270:25096-25101.
4. Kato H, Suzuki H, Tajima S. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
5. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
6. 2+ mobilization and protein kinase C activation. J Biol Chem. 1989;264:526-530.
7. Naftilan A, Pratt RE, Eldridge CS, Lin HL, Dzau V. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension. 1989;13:706-711.
8. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
9. Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, Williams RS, Sukhatme VP, Vetter H. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hypertens. 1993:11:927-934.
10. Clark AJ, Balla T, Jones MR, Catt KJ. Stimulation of early gene expression by angiotensin II in bovine adrenal glomerulosa cells: roles of calcium and protein kinase C. Mol Endocrinol. 1992;6:1889-1898.
11. Li J, Brasier AR. Angiotensinogen gene activation by AII is mediated by the Rel A (NF-κB p65) transcription factor: one mechanism for the renin angiotensin system (RAS) positive feedback loop in hepatocytes. Mol Endocrinol. 1996;10:252-264.
12. Bourcier T, Sukhova G, Libby P. The nuclear factor-κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997;272:15817-15824.
13. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 1994;10:405-455.
14. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27:465-475.
15. Brasier AR, Jamaluddin M, Casola A, Duan W, Shen Q, Garofalo R. A promoter recruitment mechanism for TNFα-induced IL-8 transcription in type II pulmonary epithelial cells: dependence on nuclear abundance of Rel A, NF-κB1 and c-Rel transcription factors. J Biol Chem. 1998;273: 3551-3561.
16. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection, Immunol Rev. 1992;127:25-50.
17. Loppnow H, Libby P. Proliferating or interleukin-1 activated human vascular smooth muscle cells secrete copious IL-6. J Clin Invest. 1990; 85:731-738.
18. Gaumond F, Fortin D, Stankova J, Rola-Pleszczynski M. Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells. J Cardiovasc Pharmacol. 1997;30:169-175.
19. Beasley D. Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways. J Cardiovasc Pharmacol. 1997;29:323-330.
20. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin-6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713-H1717.
21. Loppnow H, Bil R, Hirt S, Schonbeck W, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD. Platelet derived IL-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood. 1998;91:134-141.
22. Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, Kishimoto T. Structure and expression of human B-cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 1987;6:2939-2945.
23. Gunther S, Alexander RW, Atkinson WJ, Gimbrone M Jr. Functional angiotensin II receptors in cultured vascular smooth muscle. J Cell Biol. 1982;92:289-298.
24. Azuma H. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996;93:12439-12444.
25. Brasier AR, Tate JE, Habener JF. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques. 1989; 7:1116-1122.
26. Garofalo R, Sabry M, Jamaluddin M, Yu RK, Casola A, Ogra PL, Brasier AR. Transcriptional activation of the interleukin-8 gene by RSV infection in alveolar epithelial cells: nuclear translocation of the Rel A transcription factor as a mechanism producing airway mucosal inflammation. J Virol. 1996;70:8773-8781.
27. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. 1996;27:1009-1017.
28. Han Y, Brasier AR. Mechanism for biphasic Rel A: NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J Biol Chem. 1997;272:9823-9830.
29. Grumont RJ, Fecondo J, Gerondakis S. Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-κB1 that can function as a transactivator of NF-κB-regulated transcription. Mol Cell Biol. 1994;14:8460-8470.
30. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban MB, Kourilsky P, Baeuerle PA, Israel A. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 1990;62:1007-1018.
31. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-kB. Cell. 1994;78:773-785.
32. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
33. Obata H, Biro S, Armia N, Kaieda H, Kihara T, Eto Hi, Miyata M, Tanaka H. NF-κB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem Biophys Res Comm. 1996;224:27-32.
34. Mercurio F, DiDonato JA, Rosette C, Karin M. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 1993;7:705-718.
35. Baldassarre F, Mallardo M, Mezza E, Scala G, Quinto I. Regulation of NF-kB through the nuclear processing of p105 (NF-kB1) in Epstein-Barr Virus-immortalized B cell lines. Mol Cell Biol. 1995;270:31244-31248.
36. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 1995;80:573-582.
37. Rice NR, Ernst MK. In vivo control of NF-κB activation by IκB alpha. EMBO J. 1993;12:4685-4695.
38. Ernst MK, Dunn LL, Rice NR. The PEST-like sequence of IκB is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or Rel A homodimers. Mol Cell Biol. 1995;15: 872-882.
39. Bash J, Zong WX, Gelinas C. c-Rel arrests the proliferation of HeLa cells and affects critical regulations of the G1/S-phase transition. Mol Cell Biol. 1997;17:6526-6536.
40. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Kneuchel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.